Latigo Biotherapeutics
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
1
Funding Rounds
$150.0m
Money raised
Overview
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Latigo Biotherapeutics has raised a total of $150m in funding over 1 rounds.
Key Insights:
- Latigo Biotherapeutics March 2025 Series B Funding Round: $150m
Latigo Biotherapeutics March 2025 Series B Funding Round
$150m
Industries
Latigo Biotherapeutics is active in the following industries: